BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 31554641)

  • 1. The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation.
    Wang L; Babikir H; Müller S; Yagnik G; Shamardani K; Catalan F; Kohanbash G; Alvarado B; Di Lullo E; Kriegstein A; Shah S; Wadhwa H; Chang SM; Phillips JJ; Aghi MK; Diaz AA
    Cancer Discov; 2019 Dec; 9(12):1708-1719. PubMed ID: 31554641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
    Steponaitis G; Tamasauskas A
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
    Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
    J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
    Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
    Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
    Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
    Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
    Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
    Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
    [No Abstract]   [Full Text] [Related]  

  • 14. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Rimkus TK; Carpenter RL; Sirkisoon S; Zhu D; Pasche BC; Chan MD; Lesser GJ; Tatter SB; Watabe K; Debinski W; Lo HW
    Cancer Res; 2018 May; 78(10):2589-2600. PubMed ID: 29463580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.
    Teng J; da Hora CC; Kantar RS; Nakano I; Wakimoto H; Batchelor TT; Chiocca EA; Badr CE; Tannous BA
    Neuro Oncol; 2017 Jun; 19(6):820-832. PubMed ID: 28062830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
    Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
    Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
    Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Heterogeneous Cellular States of Glioblastoma Stem Cells Revealed by Single Cell Analysis.
    Yan H; Zhu J; Ping Y; Yan M; Liao G; Yuan H; Zhou Y; Xiang F; Pang B; Xu J; Pang L
    Stem Cells; 2023 Mar; 41(2):111-125. PubMed ID: 36583266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.